# ATMEKSI

NDC: 69528-701
Generic name: methocarbamol
Labeler / Manufacturer: Rosemont Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20251222

FDA application: NDA219843

## Active ingredients

- METHOCARBAMOL: 750 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69528-701"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69528-701
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62de7345-613b-4838-96e5-aceca3cea6b2